Page 1

From Data Aggregation to Improved Financial & Clinical Outcomes... What is possible now?

Scott Pryde BravoSolution UK

ŠALL RIGHTS RESERVED - Confidential

1


Alignment, Governance & Information

# Field Safety Notices

ŠALL RIGHTS RESERVED - Confidential

2


Reimbursement, Cost & Revenue Leakage

ŠALL RIGHTS RESERVED - Confidential

3


Underpinning Savings Initiatives

ŠALL RIGHTS RESERVED - Confidential

4


Hospital Spend Data Quality

NB One exception: Typically where there is a significant peak in Building and Construction works, the data quality drops to very low in that category as data on major works is almost always held on a separate construction system

ŠALL RIGHTS RESERVED - Confidential

5


Misleading Data

©ALL RIGHTS RESERVED - Confidential

6


MPN Overlap & Variety by Trust

% Overlap

% Common SKU by No. Of Trusts

# of Organisations ŠALL RIGHTS RESERVED - Confidential

7


What’s in a number ?

(Asset Identifier)(Organisation ID )(ProductCode)(Lot No.) XX(Serial No.)XXX

[C1 (8004) 12345699999 157004070 (19) 9999999 (21) 99999999

What’s not ? Catalogue Ref: 157004070 - C-STEM AMT SIZE1 STD OFFSET - EACH eClass:

Medical Prosthesis – Joint Replacement Hips

Benchmark:

Medical Devices - Orthopaedic – Primary – Hip - Stem – Uncemented

©ALL RIGHTS RESERVED - Confidential

8


Aggregation & Classification

ŠALL RIGHTS RESERVED - Confidential

9


Price Benchmarking

ŠALL RIGHTS RESERVED - Confidential

10


Evidence Tracking

ŠALL RIGHTS RESERVED - Confidential

11


Other Medical category examples ...

Trauma Nail Demand Volatility / Time

ŠALL RIGHTS RESERVED - Confidential

12


Opportunity Analysis & Guidance

©ALL RIGHTS RESERVED - Confidential

Spend

£557,160

% Savings

Value

Complexity

A

57%

£320,000

10

B

52%

£291,000

9

C D E F

27% 17% 13% -18%

£150,000 £96,000 £70,000 -£100,000

6 3 1 0

Aggressive brand repositioning to lower price high evidence cemented products e.g. Lubinus SPII, National Regional collaborative bulk commitment and surgeon led negotiation, Manage Consignments directly Alignment with National lowest price clinical policy and brand usage, Significant shift from uncemented to cemented products. Cllaborative, surgeon led negotiation and bulk commitment to maximise leverage Alignment with National average price aligning with technology indicator averages and brand choices. Collaborative, surgeon led negotiation and bulk commitment to maximise leverage Consolidate current brand usage and surgeon led commercial negotiation Ceramic on Ceramic - reduce to national average. Uncontroled brand usage & supply base fragmentation

13


Shared Market Intelligence

ŠALL RIGHTS RESERVED - Confidential

14


Summary

• Investing in data aggregation is essential alongside improving systems & standards • Data aggregation, analysis & information sharing is possible now • Improved financial and clinical outcomes will follow • BUT ..... information is a compass not a silver bullet ... delivery competency will still be required to achieve value • Co-operate to share market, technology , strategy expertise & knowledge across the system

©ALL RIGHTS RESERVED - Confidential

15


Executive Briefings

Hospital Benchmarking & Analytics Understanding GS1 & Data Aggregation Outcome led Contract Management MedTech Market Analysis Inventory, Demand & Utilisation Analytics Clinical Commissioning Group Spend Analysis CCG Non-Medical Auctions & Strategies

Scott Pryde BravoSolution UK

ŠALL RIGHTS RESERVED - Confidential

16


From Health Spend Data to Improved Financial & Clinical Outcomes  
Advertisement
Read more
Read more
Similar to
Popular now
Just for you